Clinical Trial Update: Phase 3 Trial to Evaluate the Efficacy and Safety of YYC506. [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating YYC506 for dyslipidemias is in progress, with status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemias

Drugs mentioned

• YYC506

Snippet

Sponsor: Yooyoung Pharmaceutical Co., Ltd. | Conditions: Dyslipidemias | Phase 3 | Status: UNKNOWN